Back to Home
On-Demand Webinar

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

Release Date

November 25, 2024

Expiration Date

November 26, 2025

Credits

1 On-Demand

Topics

Oncology

This activity was originally broadcast as part of the 2024 Directions in Oncology Pharmacy® conference.

The patient cases discussion portion of the program also includes discussion on endometrial cancer.

Program Description

Immune checkpoint inhibitors are a type of immunotherapy used in the treatment of various tumor types, but they can cause unique immune-related adverse events (irAEs) that require pharmacist expertise. As these agents become more prevalent in the oncology treatment landscape, the roles of pharmacists will continue to expand to encompass patient monitoring, identifying, and managing irAEs. Early detection and treatment of irAEs has been shown to improve patient outcomes. This session will address concepts related to early irAE recognition in real-world clinical practice, management of reversible and irreversible irAEs, and patient education. The case discussions incorporated within this program will emphasize pharmacist-led initiatives to address challenges and barriers to the early identification of clinically significant irAEs, as well as best practices for short-term and long-term follow-up.


Target audience: Oncology pharmacists

Type of activity: Application
Release date: November 25, 2024
Expiration date: November 25, 2025

Time to complete activity: 1.0 hour

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Apply knowledge of immune-related adverse events (irAE) characteristics, risk factors for development, and appropriate monitoring requirements to promptly identify toxicities of checkpoint inhibitor treatment
  • Manage steroid tapers for individual patients, considering the type and severity of irAEs and patient characteristics
  • Implement strategies for identification and management of immune-mediated endocrinopathies
  • Provide comprehensive patient education on immune-related adverse events, stressing early recognition and reporting
Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

This activity is supported by educational grant from Merck & Co, Inc, Rahway, NJ, USA.

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Related Content

Course

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

Create Account